News

NLC formally founded and registered the new NLC Stepping Stone Fund

NLC – The European Healthtech Venture Builder formally founded and registered the new NLC Stepping Stone Fund. This means that the ‘marketing phase’ of…

FlowView Diagnostics 

Multi-parameter flow cytometry is a powerful analytical tool, enabling rapid measurement of multiple, physical and chemical characteristics of individual cells. Examples of clinical applications…

Lamina

Cartilage damage in the knee affects millions of people worldwide with a continued rise in incidence. Currently, the only conventional solutions are symptoms (pain,…

NLC and MD squared conclude Framework Agreement for Venture Support

Amsterdam/Eindhoven NLC – the European HealthTech Venture Builder, has concluded a Framework Agreement with the Eindhoven based MD squared, a Medical Consultancy for Medical…

Do’s and don’ts when filing a patent

One of the most important, yet also most daunting and complicated tasks in the process of bringing an invention to the market, is securing…

NLC obtains the B Corp certificate: business as a force for good

NLC is extremely proud to announce that as of March 2020, it became a Certified B Corporation. That means that the non-profit B Lab…

Let’s embrace our European fragmentation and work together to fight corona

Europe has all the ingredients to develop a vaccine for COVID-19. Read about the health innovation ecosystem of Europe and what we can do…

Concord Neonatal achieves CE mark for the Concord Birth Trolley

PRESS RELEASE: Leiden, 4 September 2019 – Today Concord Neonatal is delivering brand-new Concord Birth Trolley’s to a number of Dutch hospitals, after achieving…

Concord Neonatal just launched a great animation video explaining why we are so passionate about Concord

Interview Bert Arjan Millenaar with Paul van Liempt

Interview (in Dutch but subtitled in English) with Paul van Liempt, explaining the NLC – The Healthtech Venture Builder way of bringing science to life….